¹Ì±¹ÀÇ À¯¹æ º¸Çü¹° ¹× Àç°Ç ±â±â ½ÃÀå : Medtech 360
Breast Implants and Reconstructive Devices | Medtech 360 | Market Insights | United States
»óǰÄÚµå : 1522888
¸®¼­Ä¡»ç : Clarivate
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 10,388 £Ü 14,201,000
Web Access and PDF Download (Corporate Use License) help
µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½º ÀÔ´Ï´Ù. À̸ÞÀÏ·Î ¸µÅ©¿Í ºñ¹Ð¹øÈ£¸¦ º¸³» µå¸³´Ï´Ù. ÀÎÅÍ³Ý ¿¬°á·Î ¿­¶÷ÀÌ °¡´ÉÇϰí PDF º¸°í¼­ ´Ù¿î·Îµå°¡ °¡´ÉÇÕ´Ï´Ù. ÀμⰡ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â PDF ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¹Ì±¹ÀÇ À¯¹æ º¸Çü¹° ¹× Àç°Ç ±â±â ½ÃÀåÀº ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î 2033³â±îÁö °ßÁ¶ÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î Àü¸ÁµÇ¸ç, 3D ÇÁ¸°ÆÃ ÀÓÇöõÆ® ¹× »ýü ÀûÇÕ¼º Àç·á¿Í °°Àº ±â¼ú ¹ßÀüÀ¸·Î Á¦Ç° Á¦°ø°ú ȯÀÚ °á°ú¸¦ °³¼±ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ý¸é, À¯¹æ º¸Çü¹° ½ÃÀåÀº °ú°Å À¯¹æ º¸Çü¹° °ü·Ã ¾ÈÀü¼º ¿ì·Á¿Í ºÎÀÛ¿ë ¹ß»ý °¡´É¼ºÀ¸·Î ÀÎÇÑ ±ÔÁ¦ À庮°ú »çȸÀû ȸÀÇ·ÐÀÌ Áö¼ÓµÇ´Â µî ¿©·¯ µµÀü °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. Á¦Á¶¾÷üµéÀº ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇϱâ À§ÇØ Çõ½ÅÀûÀÎ µðÀÚÀΰú ¾ö°ÝÇÑ ÀÓ»ó½ÃÇè¿¡ ÁßÁ¡À» µÎ°í ÀÖÀ¸¸ç, ¹Ì±¹ ½ÄǰÀǾ౹(FDA)Àº ¾ö°ÝÇÑ °¨µ¶°ú ¾÷µ¥ÀÌÆ®µÈ °¡À̵å¶óÀÎÀ» ÅëÇØ ½ÃÀå ¿ªÇп¡ Áß¿äÇÑ ¿ªÇÒÀ» °è¼ÓÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¹Ì±¹ÀÇ À¯¹æ º¸Çü¹° ¹× Àç°Ç ±â±â ½ÃÀåÀÇ Ãֽе¿ÇâÀ» Á¶»çÇÏ¿© Àü¹ÝÀûÀÎ ½ÃÀå µ¿Çâ(2019-2033³â)¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ µ¥ÀÌÅÍ¿Í ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¹Ì±¹ÀÇ À¯¹æ º¸Çü¹° ¹× Àç°Ç ±â±â ½ÃÀåÀº ¾ÈÀü¿¡ ´ëÇÑ ¿ì·Á¿Í ¼ö¼ú ÈÄ ÇÕº´Áõ À§Çè µîÀÇ À庮¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù.

FDA´Â À¯¹æ º¸Çü¹° ¹× °ü·Ã Á¦Ç°ÀÇ ¾ÈÀü¼º¿¡ ´ëÇÑ ¸ð´ÏÅ͸µÀ» °­È­Çϰí ÀÖ½À´Ï´Ù.

À¯¹æ º¸Çü¹° ¹× Àç°Ç ±â±âÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» ÀÔÁõÇϱâ À§Çؼ­´Â Àå±âÀûÀÎ ÀÓ»ó µ¥ÀÌÅÍ ¼öÁý ¹× ºÐ¼®ÀÌ ÇʼöÀûÀÔ´Ï´Ù.

¸ñÂ÷

¹Ì±¹

°³¿ä

ÁÖ¿ä ¿ä¾à

ÁÖ¿ä º¸°í¼­ ¾÷µ¥ÀÌÆ®

À¯¹æ ÀÓÇöõÆ® ¹× Àç°Ç ±â±â ½ÃÀå

À¯¹æ ÀÓÇöõÆ® ½ÃÀå

Á¶Á÷ È®Àå±â ½ÃÀå

¹«¼¼Æ÷¼º ÇǺΠ±âÁú ½ÃÀå

ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The US breast implant and reconstructive device market will expand steadily through 2033, driven by increasing demand for minimally invasive procedures. Technological advancements, such as 3-D-printed implants and biocompatible materials, are enhancing product offerings and patient outcomes. However, the market faces challenges including regulatory hurdles and ongoing public skepticism due to prior safety concerns related to breast implants and the potential for adverse events. Manufacturers are focusing on innovative designs and rigorous clinical trials to ensure safety and efficacy, while the FDA continues to play a crucial role in shaping market dynamics through stringent oversight and updated guidelines.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for breast implants and reconstructive devices in the US from 2019 through 2033.

The US breast implant and reconstructive device market faces hurdles such as safety concerns and the risk of postoperative complications.

The FDA has increased its scrutiny on the safety of breast implants and related products.

The collection and analysis of long-term clinical data is essential in demonstrating the safety and efficacy of breast implants and reconstructive devices.

Table of Contents

United States

Abstract

Executive Summary

Key Report Updates

Breast Implant and Reconstructive Device Market

Breast Implant Market

Tissue Expander Market

Acellular Dermal Matrix Market

Appendix

Tables and Figures

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â